An update on methods for sarcopenia diagnosis: from bench to bedside

Abstract

Sarcopenia has been recognized as an age-related syndrome characterized by low muscle mass, low muscle strength, and low physical performance that is associated with increased likelihood of adverse outcomes including falls, fractures, hospitalization, frailty and mortality. Therefore, it is necessary to identify the condition early for applying intervention and prevention of the disastrous consequences of sarcopenia if left untreated. Clinical definition and diagnostic criteria for sarcopenia have been developed in the last years and different tools have been proposed for screening subjects with sarcopenia, evaluating the muscle mass, the muscle strength and the physical performance. In this review we analyzed the diagnostic criteria of sarcopenia and examined the current assessment tools used for the diagnosis and screening of sarcopenia.

Greek Translation, Cultural Adaptation and Validation of the Mini Sarcopenia Risk Assessment Questionnaire, to Evaluate Sarcopenia in Greek Elderly at a Hospital Setting

“…However, the SARC-F questionnaire, as supported in the literature, is revealed to have a high specificity but low sensitivity, according to the EWGSOP2 criteria, therefore Rossi et al designed an additional questionnaire (Mini Sarcopenia Risk Assessment questionnaire) as a pre-screening tool for sarcopenia risk assessment in the elderly, which is supported to be reliable and validated [ 15 ]. The SARC-F questionnaire has been referred to as being characterized mostly as a subjective evaluation that is performed by a subject or caregiver and is orientated towards assessing physical function and disability, while the MSRA questionnaire provides more objective and measurable answers in seven domains aimed at assessing muscle mass and strength loss [ 16 , 17 ].…”